Delivery Order SPE2DP20D0002-SPE2DP22F4655
Award Date 5/17/22
Potential Completion Date 5/24/22
Potential Value $294K
Federal Agency
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Parsippany, NJ 07054, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- <p>The Defense Logistics Agency Troop Support Medical (DOD - DLA) awarded a $305,393.76 firm fixed price delivery order contract to Teva Pharmaceuticals USA, Inc. of Parsippany, New Jersey. The contract is to provide adenovirus type 4 from February 22, 2023 through February 28, 2023 at the place of performance in Parsippany, New Jersey. Teva Pharmaceuticals USA, Inc. will serve as the prime contractor to supply adenovirus type 4 to the Defense Logistics Agency Troop Support Medical.</p>
- The Defense Logistics Agency Troop Support Medical awarded Teva Pharmaceuticals USA, Inc. a $293,647.86 firm fixed price delivery order contract to provide Adenovirus Type 4. The place of performance will be Teva Pharmaceuticals' facility located in Parsippany, New Jersey. The contract period of performance spans from June 14, 2022 to June 28, 2022. Teva Pharmaceuticals will serve as the prime contractor to supply the Defense Logistics Agency with Adenovirus Type 4, a virus that causes...
- <p>The Defense Logistics Agency Troop Support Medical (DOD - DLA) awarded Teva Pharmaceuticals USA, Inc. a $293,647.86 firm fixed price delivery order contract to provide Adenovirus Type 4 from January 18, 2022 through January 25, 2022. The place of performance will be Teva Pharmaceuticals' facility located in Parsippany, New Jersey. No subcontractors were identified.</p>
- <p>The Defense Logistics Agency Troop Support Medical (DOD - DLA) awarded Teva Pharmaceuticals USA, Inc. a $293,647.86 firm fixed price delivery order contract to provide adenovirus type 4 from its Parsippany, New Jersey facility. The contract has a period of performance starting on May 17, 2022 and ending on May 24, 2022. Teva Pharmaceuticals USA, Inc. will serve as the prime contractor to supply adenovirus type 4 to the Defense Logistics Agency Troop Support Medical.</p>
- <p>The Defense Logistics Agency Troop Support Medical awarded Teva Pharmaceuticals USA, Inc. a $1,027,767.51 firm fixed price delivery order contract to provide Adenovirus Type 4 from its Parsippany, New Jersey facility. Teva Pharmaceuticals USA, Inc. will deliver the Adenovirus Type 4 between December 6, 2022 and December 20, 2022 to support the Defense Logistics Agency Troop Support Medical's medical requirements.</p>
- The Defense Logistics Agency Troop Support Medical (DOD - DLA) awarded Teva Pharmaceuticals USA, Inc. a $587,295.72 firm fixed price delivery order contract to provide adenovirus type 4 from April 19, 2022 through April 26, 2022. The place of performance for this contract is Parsippany, New Jersey. Teva Pharmaceuticals USA, Inc. will serve as the prime contractor to supply adenovirus type 4 to the Defense Logistics Agency Troop Support Medical. No applicable subcontractors were identified.
- The Defense Logistics Agency Troop Support Medical (DOD - DLA) awarded Teva Pharmaceuticals USA, Inc. a $305,393.76 firm fixed price delivery order contract to provide Adenovirus Type 4 from February 22, 2023 through February 28, 2023. The place of performance will be Teva Pharmaceuticals' facility located in Parsippany, New Jersey. Teva Pharmaceuticals will serve as the prime contractor to supply the Adenovirus Type 4 to the Defense Logistics Agency Troop Support Medical. No subcontractors were...
- The Defense Logistics Agency Troop Support Medical (DOD - DLA) awarded Teva Pharmaceuticals Usa, Inc. a $458,090.64 firm fixed price delivery order contract to provide adenovirus type 4. The contract has a period of performance starting on May 17, 2023 through May 23, 2023 and will be performed in Parsippany, New Jersey. Teva Pharmaceuticals Usa, Inc. is the prime contractor for this contract to supply the Defense Logistics Agency Troop Support Medical with adenovirus type 4, a virus that causes...
- <p>The Defense Logistics Agency Troop Support Medical (DOD - DLA) awarded Teva Pharmaceuticals USA, Inc. a $293,647.86 firm fixed price delivery order contract to provide Adenovirus Type 4 from its Parsippany, New Jersey location. The contract period of performance runs from June 14, 2022 through June 28, 2022. Teva Pharmaceuticals USA, Inc. will supply the Adenovirus Type 4 vaccine as the prime contractor, with no applicable subcontractors mentioned.</p>
- <p>The Defense Logistics Agency Troop Support Medical (DOD - DLA) awarded Teva Pharmaceuticals USA, Inc. a $610,787.52 firm fixed price delivery order contract to provide Adenovirus Type 4 from June 20, 2023 through June 27, 2023. The place of performance will be Teva Pharmaceuticals' facility located in Parsippany, New Jersey. No subcontractors were identified.</p>